Sofinnova Partners SAS - 11 Jan 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role: 10%+ Owner
Signature: Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner
Issuer symbol: N/A
Transactions as of: 11 Jan 2022
Net transactions value: +$3,520,000
Form type: 4
Filing time: 13 Jan 2022, 15:36:02 UTC
Previous filing: 06 Jan 2022
Next filing: 17 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CINC	Common Stock	Conversion of derivative security		+3,867,646			3,867,646	11 Jan 2022	By Sofinnova Capital IX	F1, F2
transaction	CINC	Common Stock	Purchase	$3,520,000	+220,000	+5.7%	$16.00	4,087,646	11 Jan 2022	By Sofinnova Capital IX	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CINC	Series A Preferred Stock	Conversion of derivative security	$0	-9,999,999	-100%	$0.000000^*	0	11 Jan 2022	Common Stock	2,941,176		By Sofinnova Capital IX	F1, F2
transaction	CINC	Series B Preferred Stock	Conversion of derivative security	$0	-3,150,000	-100%	$0.000000^*	0	11 Jan 2022	Common Stock	926,470		By Sofinnova Capital IX	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
F2	The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.